NAT2 and breast carcinoma: The present population-based case-control study of breast cancer in Germany evaluated the role of genetic polymorphisms in Phase I and II enzymes NAT1 and NAT2 in the AA pathway and CYP1A1, CYP1B1, GSTM1 and GSTT1 in the PAH pathway and cigarette smoke exposure in breast carcinogenesis.